Literature DB >> 21226605

Interferon-stimulated genes and their protein products: what and how?

Ernest C Borden1, Bryan R Williams.   

Abstract

Studies of the action of interferon-stimulated genes (ISGs) and their protein products have resulted in fundamental discoveries relevant to translational control, regulation of RNA stability and editing, and protein transport and turnover. Actions of ISGs will remain critical to improved clinical application of agonists and antagonists of the toll-like receptor and the interferon signaling cascades--now 25 years after the U.S. Food and Drug Administration and worldwide regulatory approval of the pharmaceutical product produced by recombinant DNA technology. Because the antiviral and cellular actions of these several hundred genes (what?) and their protein products are now being functionally (how?) further elucidated but have been comprehensively summarized to only limited extents, we have selected some of the most potently induced ISGs for review in this special issue of the Journal of Interferon & Cytokine Research.

Mesh:

Substances:

Year:  2011        PMID: 21226605     DOI: 10.1089/jir.2010.0129

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  31 in total

1.  Two independent mechanisms promote expression of an N-terminal truncated USP18 isoform with higher DeISGylation activity in the nucleus.

Authors:  Christoph Burkart; Jun-Bao Fan; Dong-Er Zhang
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

2.  The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY.

Authors:  Scott A Ezell; Christos Polytarchou; Maria Hatziapostolou; Ailan Guo; Ioannis Sanidas; Teeru Bihani; Michael J Comb; George Sourvinos; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

3.  Control of type I interferon-induced cell death by Orai1-mediated calcium entry in T cells.

Authors:  Chanyu Yue; Jonathan Soboloff; Ana M Gamero
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

4.  Computational Systems Biology of Psoriasis: Are We Ready for the Age of Omics and Systems Biomarkers?

Authors:  Tuba Sevimoglu; Kazim Yalcin Arga
Journal:  OMICS       Date:  2015-10-19

5.  25-Hydroxycholesterol Production by the Cholesterol-25-Hydroxylase Interferon-Stimulated Gene Restricts Mammalian Reovirus Infection.

Authors:  Alexandra Doms; Tatiana Sanabria; Jeanne N Hansen; Nihal Altan-Bonnet; Geoffrey H Holm
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

Review 6.  Interferons and their stimulated genes in the tumor microenvironment.

Authors:  Hyeonjoo Cheon; Ernest C Borden; George R Stark
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

7.  Gene regulatory and clinical effects of interferon β in patients with metastatic melanoma: a phase II trial.

Authors:  Ernest C Borden; Barbara Jacobs; Emese Hollovary; Lisa Rybicki; Paul Elson; Thomas Olencki; Pierre Triozzi
Journal:  J Interferon Cytokine Res       Date:  2011-01-15       Impact factor: 2.607

8.  Extended protection against phlebovirus infection conferred by recombinant adenovirus expressing consensus interferon (DEF201).

Authors:  Brian B Gowen; Jane Ennis; Eric J Sefing; Min-Hui Wong; Kie-Hoon Jung; Jeffrey D Turner
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

Review 9.  Regulation of interferon-dependent mRNA translation of target genes.

Authors:  Barbara Kroczynska; Swarna Mehrotra; Ahmet Dirim Arslan; Surinder Kaur; Leonidas C Platanias
Journal:  J Interferon Cytokine Res       Date:  2014-02-21       Impact factor: 2.607

10.  Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT).

Authors:  Hasan H Danish; Sharad Goyal; Neil K Taunk; Hao Wu; Meena S Moran; Bruce G Haffty
Journal:  Breast J       Date:  2013-03-26       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.